Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer-Reference-Cited by-同舟云学术

Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer

Published:2012-06-12 Issue:6 Volume:7 Page:e38231
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Meyerhardt Jeffrey A.,Ancukiewicz Marek,Abrams Thomas A.,Schrag Deborah,Enzinger Peter C.,Chan Jennifer A.,Kulke Matthew H.,Wolpin Brian M.,Goldstein Michael,Blaszkowsky Lawrence,Zhu Andrew X.,Elliott Meaghan,Regan Eileen,Jain Rakesh K.,Duda Dan G.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths.;R Siegel;CA Cancer J Clin,2011

2. SEER Cancer Statistics Review, 1975–2000.;L Ries,2003

3. Conventional cytotoxic and novel therapeutic concepts in colorectal cancer.;R Midgley;Expert Opin Investig Drugs,2001

4. Evolving treatment of advanced colorectal cancer.;A Cercek;Curr Oncol Rep,2010

5. Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer.;DJ Sargent;J Clin Oncol,2009

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer;Frontiers in Pharmacology;2023-09-01

2. Case report: Unique FLT4 variants associated with differential response to anlotinib in angiosarcoma;Frontiers in Oncology;2022-11-14

3. Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer;Cancer Treatment Reviews;2022-11

4. Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver Malignancies;Journal of Vascular and Interventional Radiology;2022-09

5. Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib;Anticancer Research;2021-01-30